MoneyWorks4Me

Valiant Laboratories - Quaterly Results

07 Feb 2025 Evaluate
A decrease in the sales to Rs. 352.28 millions was observed for the quarter ended December 2024. The sales stood at Rs. 405.15 millions during the similar quarter previous year.The Total Profit for the quarter ended December 2024 of Rs. 16.00 millions grew from Rs.-35.03 millions Operating profit Margin for the quarter ended December 2024 improved to 12.90% as compared to -45.32% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 352.28 405.15 -13.05 755.91 1514.70 -50.10 1820.52 3339.10 -45.48
Other Income 6.66 17.75 -62.48 47.74 71.78 -33.49 96.82 48.63 99.10
PBIDT 12.90 -45.32 -128.46 -37.31 32.99 -213.09 12.73 399.54 -96.81
Interest 0.62 0.19 226.32 1.21 0.57 112.28 0.78 2.54 -69.29
PBDT 12.28 -45.51 -126.98 -38.52 32.42 -218.82 11.95 397.00 -96.99
Depreciation 5.09 4.94 3.04 15.19 14.46 5.05 19.48 15.63 24.63
PBT 7.19 -50.45 -114.25 -53.71 17.96 -399.05 -7.53 381.37 -101.97
TAX -8.81 -15.42 -42.87 0.17 2.38 -92.86 -10.93 91.38 -111.96
Deferred Tax -8.81 -2.06 327.67 0.17 -3.58 -104.75 -1.11 3.38 -132.84
PAT 16.00 -35.03 -145.68 -53.88 15.58 -445.83 3.40 289.99 -98.83
Equity 434.50 434.50 0.00 434.50 434.50 0.00 434.50 325.60 33.45
PBIDTM(%) 3.66 -11.19 -132.74 -4.94 2.18 -326.62 0.70 11.97 -94.16
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..